Skip to main content
search

Our Partnerships And Collaborations

Driving The Commercialization Of Cell & Gene Therapies

Cell Therapies supports the growth of the local and global cell and gene therapy sector through partnerships and collaborations with biotech, healthcare, industry, and government.

Our prime location within the Melbourne Biomedical Precinct, which houses over 40 world-class biomedical organizations, together with our partnerships with hospitals, medical research institutes, and universities, enables us to support the development and translate of cell and gene therapies from concept to commercialisation.

View our partnersTalk to us
svg+xml;charset=utf
AusBiotech
BioMelbourne Network
VCCC
Melbourne Biomedical Precinct
Peter Mac
ISCT
Royal Melbourne Hospital

Current Partners And Collaborations

Strategic Elevation Of The Ecosystem

Cell Therapies is a member of AusBiotech and an expert steering group member of the Cell and Gene Catalyst, a joint venture with AusBiotech and Medicines Australia. We are a member facility of Therapeutic Innovation Australia through the Peter MacCallum Cancer Centre’s Centre of Excellence in Cellular Immunotherapy, supporting the translation of Australian developed IP to the clinic through our GMP manufacturing expertise.

These examples are just a few of the many valuable partnerships that Cell Therapies is proud to be part of while continuing to explore new potential collaboration opportunities.

Talk to us about becoming a partner

Australia's Leading Cell & Gene Therapy CDMO

Integrated From Research To Clinic To Market

Within Australia, Cell Therapies is wholly integrated into the well-developed healthcare system and the patient pathway, enabling clinical trials with onshore manufacturing in our TGA-licensed facility. Our GMP manufacturing facility is co-located with the Peter MacCallum Cancer Centre, which has established itself as the Australian leader in cellular immunotherapy and is one of the largest cancer research hospitals in the southern hemisphere.

Talk to us
svg+xml;charset=utf
svg+xml;charset=utf

Partner With Us

Delivering The Promise Of Advacned Therapies

As part of our broader global vision, we are open to building strategic partnerships with like-minded CDMOs, healthcare institutions, technology developers, and pharma/biotech organizations who share our commitment to enabling cross-regional clinical trials and manufacturing continuity. Our collaborative model is built on shared values of quality, innovation, and operational excellence—designed to deliver streamlined support to CGT developers across geographies.

Areas of collaboration may include:

  • Seamless regional tech transfers and dual-site clinical supply models
  • Joint go-to-market activities at CGT conferences and events
  • Shared investment in enabling technologies (e.g., digital batch monitoring, closed systems)
  • Co-development of harmonized CMC platforms and regulatory documentation
  • Referral programs to support biotech expanding into APAC or requiring localized GMP support

We welcome new collaborators who share our ambition to improve access to advanced therapies through innovation and global connectivity.

Partner with us

Unrivalled experience and service from a global leader in cell and gene therapy manufacturing

To reach out to our expert team, enter your details and we will arrange a call at a time that suits you.

svg+xml;charset=utf

cell therapies is an Australian-based, globally-active commercial contract development and manufacturing company, specializing in cell therapy, gene therapy, regenerative medicine, and cellular immunotherapy products

Services
Helpful Links
Corporate

Victorian Comprehensive Cancer Centre
Level 9, 305 Grattan Street,
Melbourne, VIC,3000
Australia

+61 3 9492 4777
[email protected]

Copyright 2025 © Cell Therapies Pty Ltd – All rights reserved.